Shares of AstraZeneca plc rose 9% on the London Stock Exchange on Wednesday following a U.S.-Pfizer agreement that helped reduce uncertainty in the pharmaceutical sector. The Trump administration indicated it would seek drug-pricing agreements before implementing any tariffs.
Editorial use only Contact your sales representative for commercial and promotional uses.License this clip
More footage filed by NurPhoto videographers.